108 related articles for article (PubMed ID: 310850)
1. Purification and biochemical characterization of human lymphocyte mitogenic factor (LMF).
Rutenberg WD; al-Khalidi U; Rosen FS; Merler E
J Immunol; 1979 Feb; 122(2):723-7. PubMed ID: 310850
[TBL] [Abstract][Full Text] [Related]
2. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
3. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia.
Frank MB; Watson J; Mochizuki D; Gillis S
J Immunol; 1981 Dec; 127(6):2361-5. PubMed ID: 6975318
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of concanavalin A-induced human lymphocyte mitogenic factor (Interleukin-2) production by suppressor T lymphocytes.
Northoff H; Carter C; Oppenheim JJ
J Immunol; 1980 Oct; 125(4):1823-8. PubMed ID: 6967918
[TBL] [Abstract][Full Text] [Related]
6. The purification and properties of human T cell growth factor.
Mier JW; Gallo RC
J Immunol; 1982 Mar; 128(3):1122-7. PubMed ID: 6976987
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of lymphocyte mitogenic factor released in vivo during a cell-mediated immune reaction in the guinea pig.
Postlethwaite AE
J Immunol; 1980 Nov; 125(5):1955-8. PubMed ID: 6968767
[TBL] [Abstract][Full Text] [Related]
8. Purification and partial characterization of human intracellular B cell growth factor.
Sahasrabuddhe CG; Martin B; Maizel AL
Lymphokine Res; 1986; 5(2):127-40. PubMed ID: 3486330
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an immunosuppressive factor from malignant ascites that resembles a factor induced in vitro by carcinoembryonic antigen.
Medoff JR; Clack VD; Roche JK
J Immunol; 1986 Sep; 137(6):2057-64. PubMed ID: 3528293
[TBL] [Abstract][Full Text] [Related]
10. Partial purification of human lymphocyte-activating factor (LAF) by ultrafiltration and electrophoretic techniques.
Lachman LB; Hacker MP; Handschumacher RE
J Immunol; 1977 Dec; 119(6):2019-23. PubMed ID: 915290
[TBL] [Abstract][Full Text] [Related]
11. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
Sherris D; Stohl W; Mayer L
J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
[TBL] [Abstract][Full Text] [Related]
12. Human helper T cell factor(s) (ThF). I. Partial purification and characterization.
Hirano T; Teranishi T; Toba H; Sakaguchi N; Fukukawa T; Tsuyuguchi I
J Immunol; 1981 Feb; 126(2):517-22. PubMed ID: 6161177
[TBL] [Abstract][Full Text] [Related]
13. Humoral factors in very young NZB mice that enhance the maturation of normal B cell precursors. Partial purification and characterization.
Jyonouchi H; Kimmel MD; Lee G; Kincade PW; Good RA
J Immunol; 1985 Sep; 135(3):1891-9. PubMed ID: 3926891
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
Cameron DJ
J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
[TBL] [Abstract][Full Text] [Related]
15. Purification of human interleukin 2 produced from normal human peripheral blood mononuclear cells.
Kermani-Arab V; Uittenbogaart C; Bramhall J
Thymus; 1986; 8(1-2):3-11. PubMed ID: 3487853
[TBL] [Abstract][Full Text] [Related]
16. Characterization of guinea pig mitogenic factors. I. Evidence that antigen-induced mitogenic factor and mitogenic factor from mixed leukocyte cultures are distinct molecular entities.
Geczy CL
J Immunol; 1977 Dec; 119(6):2107-13. PubMed ID: 144166
[TBL] [Abstract][Full Text] [Related]
17. Partial purification and characterization of the human lymphocyte colony enhancing factor (LCEF).
Zeevi A; Goldman I; Rozenszajn LA
Immunology; 1978 Mar; 34(3):523-31. PubMed ID: 305893
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen-activator in human early milk: its partial purification and characterization.
Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
[TBL] [Abstract][Full Text] [Related]
19. Suppressor cell induction factor: a new mediator released by stimulated human lymphocytes and distinct from previously described lymphokines.
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1983 Jun; 130(6):2720-6. PubMed ID: 6222115
[TBL] [Abstract][Full Text] [Related]
20. Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells.
Schwyzer M; Fontana A
J Immunol; 1985 Feb; 134(2):1003-9. PubMed ID: 3871205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
